49. Systemic lupus erythematosus
827 clinical trials,   638 drugs   (DrugBank: 168 drugs),   108 drug target genes,   191 drug target pathways

Searched query = "Systemic lupus erythematosus", "SLE"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.

Search in Page e.g. "Phase 3", "Not recruiting", "Japan"
1 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT01101802
(ClinicalTrials.gov)
March 20069/4/2010Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE)A Prospective, Randomised, Double-blind, Placebo-controlled Trial Evaluating the Effects of Mycophenolate Mofetil on 'Surrogate Markers' for Atherosclerosis in Female Patients With SLE.Systemic Lupus Erythematosus;AtherosclerosisDrug: Mycophenolate mofetil;Drug: sugar pillGuy's and St Thomas' NHS Foundation TrustInstitute of Child Health, University College London, London, UK.Completed18 Years60 YearsFemale71Phase 4United Kingdom